NCT00059215 - A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) | Biotech Hunter

Enrollment

905

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions

Cardiovascular DiseasesHeart Diseases

Interventions

DRUG

Prasugrel (CS-747)

Administered orally

DRUG

Clopidogrel

Administered orally

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Boston

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4599) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Victoria

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY